Published in NIH Consens State Sci Statements on February 08, 2013
The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol (2013) 1.84
Call it cancer. Oncologist (2012) 1.18
Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer. Patient Educ Couns (2012) 1.12
The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals. BMC Fam Pract (2014) 0.88
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist. Virchows Arch (2014) 0.81
The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer. Urol Oncol (2016) 0.80
Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions. Med Care (2014) 0.79
Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness? J Cancer Res Clin Oncol (2015) 0.77
Using Electronic Health Record Data to Identify Prostate Cancer Patients That May Qualify for Active Surveillance. EGEMS (Wash DC) (2016) 0.75
The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? Int Braz J Urol (2015) 0.75
Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer. Am J Prev Med (2015) 0.75
Utilization and predictors of expectant management among elderly men with low-and intermediate-risk localized prostate cancer in U.S. urological practice. Urol Pract (2017) 0.75
International network of cancer genome projects. Nature (2010) 20.35
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2011) 9.75
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2014) 8.74
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2009) 6.66
Statistical methods for estimating usual intake of nutrients and foods: a review of the theory. J Am Diet Assoc (2006) 6.26
Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol (2002) 5.81
An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA (2008) 5.25
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Offering individual genetic research results: context matters. Sci Transl Med (2010) 4.51
Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc (2003) 4.44
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet (2013) 4.06
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA (2003) 4.01
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol (2009) 3.51
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med (2012) 3.44
Nitrate in public water supplies and the risk of colon and rectum cancers. Epidemiology (2003) 3.39
Modeling data with excess zeros and measurement error: application to evaluating relationships between episodically consumed foods and health outcomes. Biometrics (2009) 3.30
Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. JAMA (2006) 3.20
ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol (2007) 3.19
Limited Panniculectomy for Adult Buried Penis Repair. Plast Reconstr Surg (2015) 3.11
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07
Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making (2007) 3.02
Reliability of reporting on life-style and agricultural factors by a sample of participants in the Agricultural Health Study from Iowa. Epidemiology (2002) 3.00
A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health A (2006) 2.78
Impact of graft position on failure of single-stage bulbar urethroplasties with buccal mucosa graft. Urology (2013) 2.73
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst (2007) 2.70
Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med (2008) 2.64
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol (2002) 2.63
Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood (2010) 2.58
Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology (2005) 2.56
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med (2006) 2.52
Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol (2002) 2.51
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
The food propensity questionnaire: concept, development, and validation for use as a covariate in a model to estimate usual food intake. J Am Diet Assoc (2006) 2.47
Improved survival of follicular lymphoma patients in the United States. J Clin Oncol (2005) 2.46
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst (2002) 2.44
Science and regulation. Regulating direct-to-consumer personal genome testing. Science (2010) 2.40
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am J Epidemiol (2003) 2.39
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36
Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making (2007) 2.34
Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus (2006) 2.25
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw (2011) 2.24
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.21
Tonsillectomy does not improve bedwetting: results of a prospective controlled trial. J Urol (2010) 2.19
Pharmacogenetic testing: not as simple as it seems. Genet Med (2008) 2.18
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol (2007) 2.17
Outcomes of endoscopic realignment of pelvic fracture associated urethral injuries at a level 1 trauma center. J Urol (2012) 2.17
The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol (2009) 2.16
Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv (2011) 2.15
Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol (2013) 2.15
Where do patients with cancer in Iowa receive radiation therapy? J Oncol Pract (2014) 2.14
Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet (2003) 2.11
What is the most cost-effective treatment for 1 to 2-cm bulbar urethral strictures: societal approach using decision analysis. Urology (2006) 2.09
The FDA and genomic tests--getting regulation right. N Engl J Med (2015) 2.09
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med (2013) 2.08
Epidemiologic association between prostatitis and prostate cancer. Urology (2002) 2.05
Urologic complications of diabetes. Diabetes Care (2005) 2.03
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03
Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology (2004) 1.97
Next-generation sequencing in the clinic: are we ready? Nat Rev Genet (2012) 1.95
Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol (2005) 1.92
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91
Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort. Diabetes Care (2009) 1.87
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol (2010) 1.85
Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol (2007) 1.80
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
First reports evaluating the effectiveness of strategies for preventing violence: early childhood home visitation. Findings from the Task Force on Community Preventive Services. MMWR Recomm Rep (2003) 1.77
Older adults in the rural South are not meeting healthful eating guidelines. J Am Diet Assoc (2007) 1.74
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry. J Natl Compr Canc Netw (2009) 1.73
Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer. J Clin Oncol (2011) 1.69
Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol (2008) 1.69
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood (2007) 1.63